Hearing screening follow-up for congenital infection in newborns
Part of Brain & nervous system, Ear, nose & throat, Infections clinical trials.
This study checks if babies who fail their newborn hearing test might have a hidden infection from birth. It looks for cytomegalovirus (CMV), a common virus that can affect hearing, using a simple test.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is between birth and 1 month old
- Your baby had a hearing test that gave an unclear result (called T2) on one or both ears
- This hearing test happened between August 2024 and July 2025
- Your baby has not already tested positive for CMV after 1 month of life
- Your baby is not having a CMV test for another reason already
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study will follow children born in New York State who were tested for cytomegalovirus (CMV) as newborns. It aims to understand their long-term health and development, whether they were confirmed to have CMV, a false positive, or even a late detection if born early.
This research study examines blood samples from newborns to identify biological markers (proteins and genetic signals) that could help detect and understand congenital cytomegalovirus (CMV) infection—a virus some babies are born with. Finding these markers might help doctors identify infected infants earlier and develop better treatments.
This study looks at the genes of babies up to 6 months old who didn't pass newborn hearing tests. The goal is to find genetic causes of hearing loss, which could help families understand their child's condition and plan for care.
This is an observational study that looks at how babies with congenital CMV infection are diagnosed and managed in real life. It may help doctors understand which care approaches are used and how they relate to outcomes over time.
This study tests if giving antiviral medicine for 4 to 6 months helps babies born with cytomegalovirus (CMV) infection that affects their brain and development. It aims to see if longer treatment can prevent problems like hearing loss or delayed growth.
This Phase 2 trial tests an immune treatment made from donor T-cells to help the body fight congenital CMV infection in newborns. It may be an option if your baby is very young, has evidence of CMV infection, and meets specific blood, kidney, and liver safety limits.
Hear when a new Neonatal Hearing Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.